Botulism (or botulism poisoning) is an uncommon, yet intense disease that transmits through food, contact with tainted soil, or through an open injury. Without early treatment, botulism can lead to paralysis, breathing challenges, and death.
Global Botulism Market: Introduction
- Botulism (or botulism poisoning) is an uncommon, yet intense disease that transmits through food, contact with tainted soil, or through an open injury. Without early treatment, botulism can lead to paralysis, breathing challenges, and death.
Read Report Overview - https://www.transparencymarketresearch.com/botulism-market.html
- Botulism poisoning is caused due to a toxin produced by a kind of bacteria known as Clostridium botulinum. These bacteria can flourish in conditions deprived of oxygen. For instance, certain food sources such as preserved or fermented food and homemade canned food are potent breeding ground for bacteria.
- Botulinum toxins are one of the deadliest substances known. This toxin blocks the functionality of nervous system, which can lead to respiratory and muscular paralysis.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77834
Different types of botulism are:
- Infant botulism
- Foodborne botulism
- Wound botulism
- Inhalation botulism
- Other types
Key Drivers and Restraint of Global Botulism Market
- Technological advancements in the health care industry have led to introduction of various types of antitoxin and antibiotics for the treatment of botulism. Large number of research & development initiatives and availability of new solutions are projected to be the key drivers of the global botulism market during the forecast period.
- According to the Centers for Disease Control and Prevention (CDC), in 2017, 182 confirmed cases of botulism were reported in the U. S., out of which 141 (77%) were infant botulism, 19 (10%) were foodborne botulism, 19 (10%) were wound botulism, and 3 (1%) were other types. Increase in incidence rate of botulism is anticipated to drive the global botulism market.
- However, significant investment required for development of botulism treatments and late & incorrect diagnosis of the disease are expected to restrain the global botulism market
- Inadequate knowledge and awareness about botulism, lack of proper health care infrastructure in emerging regions, and unaffordability in middle-income countries are the other restraints of the global botulism market
Request for Analysis of COVID-19 Impact on Botulism Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77834
North America to Lead Global Botulism Market
- In terms of region, the global botulism market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America was the largest market in 2019 due to rise in prevalence of clostridium botulinum diseases in the region. According to the CDC, on average 145 cases of botulism are recorded in the U.S. every year. Of these, around 15% are foodborne botulism, 65% are infant botulism, and 20% are wound botulism.
- Europe is projected to account for significant share of the global botulism market during the forecast period. This is attributed to rise in awareness about various bacteria such as Clostridium botulinum and stringent government guidelines to ensure better security of individuals in the region. For example, in January 2019, Grupo Dia called back a batch of canned sardines in olive oil from Spain and Portugal due to risk of botulinum toxin that can cause botulism.
- The botulism market in Asia Pacific is anticipated to grow at the fastest pace during the forecast period because of the expanding patient pool, increase in awareness about health, government initiatives to improve health care infrastructure, and availability of modern treatment techniques. Moreover, rise in prevalence of communicable diseases drives the botulism market in Asia Pacific.
- The market in Latin America and Middle East & Africa is expected to witness sluggish growth during the forecast period due to lack of awareness and restricted access and availability of treatment facilities
- In the Middle East, the United Arab Emirates and Saudi Arabia are the largest markets owing to advancements in the health care industry and increase in availability of specialty care centers
Pre Book Botulism Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=77834<ype=S
Key Players Operating in Global Botulism Market
- Alphavax, Inc.
- Ology Bioservices
- Morphotek, Inc.
- Bausch Health Companies, Inc.
- Medytox
- Molecular Targeting Technologies, Inc.
- Lanzhou Institute of Biological Products Co., Ltd.
- Metabiologics, Inc.
- Merz Pharma
- Galderma SA
- Revance Therapeutics, Inc.
- Emergent BioSolutions, Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/